Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend]
SEC Accession No. 0001104659-24-067125
Filing Date
2024-05-31
Accepted
2024-05-31 16:03:33
Documents
165

Document Format Files

Seq Description Document Type Size
1 FORM S-1/A aeon-20240331xs1a.htm   iXBRL S-1/A 6490167
2 EXHIBIT 5.1 aeon-20240331xex5d1.htm EX-5.1 39181
3 EXHIBIT-23.1 aeon-20240331xex23d1.htm EX-23.1 2232
4 EXHIBIT-23.2 aeon-20240331xex23d2.htm EX-23.2 3512
5 EX-FILING FEES aeon-20240331xexfees.htm EX-FILING FEES 174959
11 GRAPHIC aeon-20240331xs1a009.jpg GRAPHIC 12457
12 GRAPHIC aeon-20240331xs1a012.jpg GRAPHIC 64185
13 GRAPHIC aeon-20240331xex5d1001.jpg GRAPHIC 6044
14 GRAPHIC aeon-20240331xex5d1002.jpg GRAPHIC 1836
15 GRAPHIC aeon-20240331xex23d2001.jpg GRAPHIC 5566
  Complete submission text file 0001104659-24-067125.txt   25489473

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION SCHEMA aeon-20240331.xsd EX-101.SCH 143082
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE aeon-20240331_def.xml EX-101.DEF 821683
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE aeon-20240331_lab.xml EX-101.LAB 812090
9 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE aeon-20240331_cal.xml EX-101.CAL 72319
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE aeon-20240331_pre.xml EX-101.PRE 1256959
169 EXTRACTED XBRL INSTANCE DOCUMENT aeon-20240331xs1a_htm.xml XML 3674275
Mailing Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614
Business Address 5 PARK PLAZA SUITE 1750 IRVINE CA 92614 (949) 354-6499
AEON Biopharma, Inc. (Filer) CIK: 0001837607 (see all company filings)

EIN.: 853940478 | State of Incorp.: DE | Fiscal Year End: 1231
Type: S-1/A | Act: 33 | File No.: 333-274094 | Film No.: 241009561
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)